Hongping Ba (Xiaoxi Zhou)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Diffuse Large B Cell Lymphoma

Anti Inflammatory

Monoclonal Antibody

Top Venues

Journal for immunotherapy of cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ting Deng, Shiyuan Zhang, Min Xiao, Jia Gu, Liang Huang, Hongping Ba
A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 mut /CD79B mut diffuse large B-cell lymphoma. Cancer medicine 13 (4) (2024)
Hongping Ba, Zigang Dai, Zunyue Zhang, Peng Zhang, Bingjiao Yin, Jing Wang, Zhuoya Li, Xiaoxi Zhou
Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers. Journal for immunotherapy of cancer 11 (1) (2023)
Hongping Ba, Zigang Dai, Zunyue Zhang, Peng Zhang, Bingjiao Yin, Jing Wang, Zhuoya Li, Xiaoxi Zhou
Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers. Journal for immunotherapy of cancer 11 (1) (2023)
Tongjuan Li, Yuanyuan Zhang, Dan Peng, Xia Mao, Hongping Ba, Jianfeng Zhou
A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy. Journal for immunotherapy of cancer 7 (1) (2019)